Dr. Ulrich Tanaka

General neurologist · Peter MacCallum Cancer Centre · Australia (AU) · Neurology

Tier 3STK-0146GoodOwner MSL LOLuis Ortega

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Headache medicine
Disease interests: MIG
Scientific interests: SwitchingChronic migraineCGRP persistence
Engagement preference: Virtual
Advisory boards: 1
Publications: 4
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 3: 1 per year (assumption)

Last engaged: 24 Mar 2026 (175 days ago)
Next planned contact: 24 Mar 2027
Last 6 months vs target: 100%
1 of 1 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
24 Mar 2026	Scientific exchange	In person	Luis Ortega	Lumeva	Drug interactionsSwitching between CGRP agents	0	—	Reviewed	ENG-0201
14 Jan 2026	Scientific exchange	In person	Luis Ortega	Lumeva	Real-world persistence	0	—	Reviewed	ENG-0220

Timeline

24 Mar 2026
Scientific exchange
Drug interactions, Switching between CGRP agents
14 Jan 2026
Scientific exchange
Real-world persistence

Related stakeholders (3)

Peter MacCallum Cancer Centre

Dr. Rosa Zimmermann
General neurologist
Tier 2
Dr. Liam Eriksen
Headache specialist
Tier 3
Dr. Liam Dubois
Primary care physician
Tier 1